A take-home message of the PRAMI trial for interventionalists

AMSTERDAM — George Vetrovec, MD, a member of the Cardiology Today Editorial Board, provides expert perspective on the PRAMI trial, which suggested that preventive PCI in noninfarct coronary arteries of patients with STEMI and multivessel disease may play a role in reducing the risk for adverse CV events.

He discusses the longstanding debate surrounding what to do with nonacute lesions in the setting of acute MI, what the new PRAMI data add to the current knowledge base and questions that can be raised moving forward.

See more from ESC Congress 2013

See all meeting news coverage